Rheumatoid arthritis - NHS Choicesdoi:http://www.nhs.ukRheumatoid arthritis is a long-term condition that causes pain, swelling and stiffness in the joints.NHS ChoicesDepartment of Health
Rheumatoid arthritis affects half a million people in the UK and develops when the body’s immune system attacks itself, causing joint pain, swelling and significant disability. The disease most commonly begins in middle age, but much younger age groups can be afflicted, and until now th...
Clinical Epidemiology Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3) Catherine Vasilakis-Scaramozza 1, Katrina Wilcox Hagberg 1, ...
Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune condition which affects an estimated 400,000 UK adults.1Onset is commonly between 40–50 years old, though can occur at any age, with women three times more likely affected than men.1RA is a common cause of disability; work...
We thank the Arthritis Research Campaign for their support (arc grant reference no. 17552). We would also like to acknowledge the National Health Service (NHS) Research and Development Support Fund for Guy's and St Thomas' and Lewisham NHS Trusts. We acknowledge use of DNA from the British ...
This article was originally published in theBDJas Rheumatoid arthritis – an update for general dental practitioners (2016;222:667-673). References NHS Choices. Rheumatoid arthritis. 2014. Online information available athttp://www.nhs.uk/conditions/Rheumatoid-arthritis/Pages/Introduction.aspx(accessed ...
The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. This work was funded by the IMI JU funded project BTCure, no 115142-2, and we thank Arthritis Research UK for ...
FDA WARNS UK CORONAVIRUS VARIANT MAY RESULT IN FALSE-NEGATIVE TESTS Health Secretary Matt Hancock said the drugs could save hundreds of lives. "We have worked quickly to ensure this treatment is available to NHS patients without delay, meaning hundreds of lives will be saved," Hancock said in ...
JAK inhibitors (JAKi) are targeted, small-molecule, disease-modifying therapies that are the newest class of treatments to emerge for the management of rheumatoid arthritis (RA) and the first oral disease-modifying anti-rheumatic drugs (DMARD) to demonstrate comparable clinical efficacy to biological...
来自 netag.nhs.uk 喜欢 0 阅读量: 29 作者: LS Erhorn 摘要: * NICE guidance is extensive with respect to the treatment of rheumatoid arthritis. However there may still be some small patient groups which are not catered for and there is a desire to use rituximab in these patients: ...